Selective serotonin reuptake inhibitors and congenital heart anomalies: Comparative cohort studies of women treated before and during pregnancy and their children

Journal of Clinical Psychiatry

Volumn 77, Issue 1, 2016, Pages e36-e42

  Petersen, Irene ^a   Evans, Stephen J ^c   Gilbert, Ruth ^b   Marston, Louise ^a   Nazareth, Irwin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; CLOMIPRAMINE; DOSULEPIN; ESCITALOPRAM; FLUOXETINE; HYPNOTIC AGENT; ILLICIT DRUG; LOFEPRAMINE; NEUROLEPTIC AGENT; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AGING; ALCOHOLISM; AORTA ARCH ANOMALY; AORTA COARCTATION; AORTA STENOSIS; AORTA SUBVALVULAR STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; BICUSPID AORTIC VALVE; BODY MASS; CHILD; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DEPRESSION; DEXTROCARDIA; DIABETES MELLITUS; DRUG DEPENDENCE; EBSTEIN ANOMALY; FALLOT TETRALOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INDEPENDENT VARIABLE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; MITRAL VALVE REGURGITATION; OBESITY; PATENT FORAMEN OVALE; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PULMONARY ARTERY MALFORMATION; PULMONARY ARTERY STENOSIS; PULMONARY VALVE ATRESIA; PULMONARY VALVE DISEASE; PULMONARY VALVE STENOSIS; RISK ASSESSMENT; SOCIAL ASPECT; TRICUSPID VALVE REGURGITATION; UNITED KINGDOM; ABNORMALITIES, DRUG-INDUCED; CASE CONTROL STUDY; CHEMICALLY INDUCED; COMPARATIVE STUDY; FACTUAL DATABASE; HEART DEFECTS, CONGENITAL; PREGNANCY; PRENATAL EXPOSURE; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; LIFE STYLE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS; UNITED KINGDOM; YOUNG ADULT;

EID: 84957801282     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09241     Document Type: Article

References (37)

1. Ross LE, Grigoriadis S, Mamisashvili L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry. 2013;70(4):436-443. doi:10.101/jamapsychiatry.2013.684 PubMed
2. Grigoriadis S, Vonder Porten EH, Mamisashvili L, et al. Antidepressant exposure during pregnancy and congenital malformations: is there an association? a systematic review and meta-analysis of the best evidence. J Clin Psychiatry. 2013;74(4):e293-e308. doi:10.408/JCP.12r0796 PubMed
3. Wurst KE, Poole C, Ephross SA, et al. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol. 2010;88(3):159-170. doi:10.102/bdra.20627 PubMed
4. Pedersen LH, Henriksen TB, Vestergaard M, et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ. 2009;339:b3569. doi:10.136/bmj.b3569 PubMed
5. Malm H, Artama M, Gissler M, et al. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol. 2011;118(1):111-120. doi:10.1097/AOG.0b013e31820edc PubMed
6. Oberlander TF, Warburton W, Misri S, et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol. 2008;83(1):68-76. doi:10.102/bdrb.2014 PubMed
7. Margulis AV, Abou-Ali A, Strazzeri MM, et al. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD. Pharmacoepidemiol Drug Saf. 2013;22(9):942-951.
8. Jimenez-Solem E, Andersen JT, Petersen M, et al. SSRI use during pregnancy and risk of stillbirth and neonatal mortality. Am J Psychiatry. 2013;170(3):299-304. doi:10.176/api.ajp. 2012.1081251 PubMed
9. Reis M, Källén B. Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. a register study. BMJ Open. 2013;3(2):e002166. doi:10.136/bmjopen-2012-0216 PubMed
10. Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194.e1-194.e5. doi:10.1016/j.ajog.207.07.036 PubMed
11. Huybrechts KF, Palmsten K, Mogun H, et al. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry. 2013;35(3):265-271. doi:10.1016/j.genhospsych.2012.12.010 PubMed
12. Mitchell AA, Gilboa SM, Werler MM, et al; National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol. 2011;205(1):51.e1-51.e8. doi:10.1016/j.ajog.201.02.029 PubMed
13. Kieler H, Artama M, Engeland A, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ. 2012;344:d8012. doi:10.136/bmj.d8012 PubMed
14. Grigoriadis S, Vonderporten EH, Mamisashvili L, et al. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis. BMJ. 2014;348:f6932. doi:10.136/bmj.f6932 PubMed
15. Rai D, Lee BK, Dalman C, et al. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ. 2013;346:f2059. doi:10.136/bmj.f2059 PubMed
16. Ban L, Gibson JE, West J, et al. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG. 2014;121(12):1471-1481. doi:10.1/1471-0528.12682 PubMed
17. Sadler TW. Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations. Reprod Toxicol. 2011;32(4):484-489. doi:10.1016/j.reprotox.201.09.04 PubMed
18. Grzeskowiak LE, Gilbert AL, Morrison JL. Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues. Drug Saf. 2011;34(11):1027-1048. doi:10.2165/1593130-0-0 PubMed
19. Nordeng H, van Gelder M M H J, Spigset O, et al. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol. 2012;32(2):186-194. doi:10.1097/JCP.0b013e3182490eaf PubMed
20. Jimenez-Solem E, Andersen JT, Petersen M, et al. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open. 2012;2(3):e001148. doi:10.136/bmjopen-2012-0148 PubMed
21. Howard LM, Megnin-Viggars O, Symington I, et al; Guideline Development Group. Antenatal and postnatal mental health: summary of updated NICE guidance. BMJ. 2014;349:g7394. doi:10.136/bmj.g7394 PubMed
22. Blak BT, Thompson M, Dattani H, et al. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care. 2011;19(4):251-255.
23. Lis Y, Mann RD. The VAMP Research multipurpose database in the UK J Clin Epidemiol. 1995;48(3):431-443. doi:10.1016/0895-4356 (94) 0137-F PubMed
24. Chisholm J. The Read Clinical Classification. BMJ. 1990;300(6732):1092. doi:10.136/bmj.30.6732.1092 PubMed
25. Sadler TW. Susceptible periods during embryogenesis of the heart and endocrine glands. Environ Health Perspect. 2000;108(suppl 3):555-561. doi:10.1289/ehp. 0108s35 PubMed
26. Huybrechts KF, Palmsten K, Avorn J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370(25):2397-2407. doi:10.1056/NEJMoa1312828 PubMed
27. Rait G, Walters K, Griffin M, et al. Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry. 2009;195(6):520-524. doi:10.192/bjp. bp. 108.058636 PubMed
28. Vasilakis-Scaramozza C, Aschengrau A, Cabral H, et al. Antidepressant use during early pregnancy and the risk of congenital anomalies. Pharmacotherapy. 2013;33(7):693-700. doi:10.102/phar.121 PubMed
29. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40(10):1723-1733. doi:10.1017/S032917092194 PubMed
30. Laugesen K, Telén Andersen AB, Nørgaard M, et al. Use of selective serotonin reuptake inhibitors and lifestyle among women of childbearing age: a Danish cross-sectional survey. BMJ Open. 2013;3(7):e003024. doi:10.136/bmjopen-2013-03024 PubMed
31. Huybrechts KF, Sanghani RS, Avorn J, et al. Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS ONE. 2014;9(3):e92778. doi:10.1371/journal.pone.09278 PubMed
32. Nordeng H, Ystrøm E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207-214. doi:10.107/s028-09-074-2 PubMed
33. Petersen I, Gilbert RE, Evans SJ, et al. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry. 2011;72(7):979-985. doi:10.408/JCP.10m06090blu PubMed
34. Jimenez-Solem E, Andersen JT, Petersen M, et al. Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study. PLoS ONE. 2013;8(4):e63034. doi:10.1371/journal.pone.063034 PubMed
35. Jones I, Craddock N. Bipolar disorder and childbirth: the importance of recognising risk. Br J Psychiatry. 2005;186(6):453-454. doi:10.192/bjp. 186.6.453 PubMed
36. Yonkers KA, Gotman N, Smith MV, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011;22(6):848-854.
37. Cohen LS, Nonacs RM, Bailey JW, et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Women Ment Health. 2004;7(4):217-221.